The Director-General of the Jordan Food and Drug Administration (JFDA), Dr. Nizar Mhaidat made a number of moves that reached leadership positions in the organization, according to sources that told Ammon. These moves come with the aim of enhancing the reality of providing services and the speed of their implementation, and in line with the institution’s work plans and projects during the coming period, which calls for such changes, according to the sources.
Carefully studied movements based on the optimal employment of competencies and human resources also bear assurances that the institution is based on a professional and institutional methodology that keeps pace with the developments of the next stage.
It is expected that the transfers will result in qualitative work outputs and unprecedented initiatives related to several vital files and according to priorities, with a focus on strengthening communication and openness with the industrial and commercial sectors, and field follow-up to closely identify any challenges and deal immediately with them and strive to overcome them in line with the qualitative shift witnessed by the institution.
The Director-General of the Jordan Food and Drug Administration (JFDA), Dr. Nizar Mhaidat made a number of moves that reached leadership positions in the organization, according to sources that told Ammon. These moves come with the aim of enhancing the reality of providing services and the speed of their implementation, and in line with the institution’s work plans and projects during the coming period, which calls for such changes, according to the sources.
Carefully studied movements based on the optimal employment of competencies and human resources also bear assurances that the institution is based on a professional and institutional methodology that keeps pace with the developments of the next stage.
It is expected that the transfers will result in qualitative work outputs and unprecedented initiatives related to several vital files and according to priorities, with a focus on strengthening communication and openness with the industrial and commercial sectors, and field follow-up to closely identify any challenges and deal immediately with them and strive to overcome them in line with the qualitative shift witnessed by the institution.
The Director-General of the Jordan Food and Drug Administration (JFDA), Dr. Nizar Mhaidat made a number of moves that reached leadership positions in the organization, according to sources that told Ammon. These moves come with the aim of enhancing the reality of providing services and the speed of their implementation, and in line with the institution’s work plans and projects during the coming period, which calls for such changes, according to the sources.
Carefully studied movements based on the optimal employment of competencies and human resources also bear assurances that the institution is based on a professional and institutional methodology that keeps pace with the developments of the next stage.
It is expected that the transfers will result in qualitative work outputs and unprecedented initiatives related to several vital files and according to priorities, with a focus on strengthening communication and openness with the industrial and commercial sectors, and field follow-up to closely identify any challenges and deal immediately with them and strive to overcome them in line with the qualitative shift witnessed by the institution.
comments